9.26
price down icon2.94%   -0.28
pre-market  プレマーケット:  10.88   1.62   +17.49%
loading
前日終値:
$9.54
開ける:
$9.54
24時間の取引高:
87,723
Relative Volume:
2.63
時価総額:
$121.72M
収益:
-
当期純損益:
$-8.89M
株価収益率:
-13.23
EPS:
-0.7
ネットキャッシュフロー:
$-6.48M
1週間 パフォーマンス:
-13.05%
1か月 パフォーマンス:
-24.22%
6か月 パフォーマンス:
-33.19%
1年 パフォーマンス:
-51.37%
1日の値動き範囲:
Value
$9.06
$9.82
1週間の範囲:
Value
$9.06
$11.13
52週間の値動き範囲:
Value
$9.06
$18.75

Greenwich Lifesciences Inc Stock (GLSI) Company Profile

Name
名前
Greenwich Lifesciences Inc
Name
セクター
Healthcare (1165)
Name
電話
203-434-3290
Name
住所
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Name
職員
6
Name
Twitter
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
GLSI's Discussions on Twitter

GLSI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GLSI
Greenwich Lifesciences Inc
9.26 121.72M 0 -8.89M -6.48M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-09-01 開始されました H.C. Wainwright Buy

Greenwich Lifesciences Inc (GLSI) 最新ニュース

pulisher
06:10 AM

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial - The Manila Times

06:10 AM
pulisher
06:06 AM

Greenwich Lifesciences Announces Positive Immune Response Data From FLAMINGO-01 Phase III Clinical Trial - MarketScreener

06:06 AM
pulisher
06:00 AM

Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group - Stock Titan

06:00 AM
pulisher
Apr 01, 2025

Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently - simplywall.st

Apr 01, 2025
pulisher
Mar 31, 2025

Greenwich LifeSciences Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

How To Trade (GLSI) - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-Up Period for Directors, Officers to March 2026 - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026 - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx, Alteogen - Barchart

Mar 26, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA - openPR.com

Mar 26, 2025
pulisher
Mar 25, 2025

GLSI stock touches 52-week low at $10.52 amid market challenges - Investing.com

Mar 25, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences gets DSMB approval to continue late-stage trial of GLSI-100 - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Says Preliminary Safety Data for Breast Cancer Therapy Appears Consistent With Prior Trials - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences reports positive safety data on GLSI-100 - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction - StockTitan

Mar 17, 2025
pulisher
Mar 10, 2025

Trading (GLSI) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 10, 2025
pulisher
Mar 05, 2025

Non-Small Cell Lung Cancer Clinical Trial Pipeline | 100+ Companies Pioneering the Future of Treatment - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

Learn to Evaluate (GLSI) using the Charts - news.stocktradersdaily.com

Feb 27, 2025
pulisher
Feb 22, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Sees Large Increase in Short Interest - MarketBeat

Feb 22, 2025
pulisher
Feb 21, 2025

Short Interest in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Increases By 5.1% - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verra Mobility Corporation (NASDAQ: VRRM) - PR Newswire

Feb 20, 2025
pulisher
Feb 18, 2025

Pre-market Movers: TNXP, INBS, SMMT, NDRA... - RTTNews

Feb 18, 2025
pulisher
Feb 18, 2025

Research Analysts Set Expectations for GLSI FY2024 Earnings - MarketBeat

Feb 18, 2025
pulisher
Feb 15, 2025

HC Wainwright Reiterates Buy Rating for Greenwich LifeSciences (NASDAQ:GLSI) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

What is HC Wainwright’s Estimate for GLSI FY2024 Earnings? - Defense World

Feb 15, 2025
pulisher
Feb 12, 2025

Greenwich LifeSciences reports progress in FLAMINGO-01 trial - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Given “Buy” Rating at HC Wainwright - Defense World

Feb 11, 2025
pulisher
Feb 11, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Greenwich LifeSciences, Inc. (NASDAQ: GLSI) - PR Newswire

Feb 11, 2025
pulisher
Feb 11, 2025

Walmart (NYSE:WMT) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 - GlobeNewswire

Feb 10, 2025
pulisher
Feb 10, 2025

Greenwich LifeSciences reports progress in FLAMINGO-01 trial By Investing.com - Investing.com UK

Feb 10, 2025
pulisher
Feb 10, 2025

Clinical Trial Success: Greenwich's Breast Cancer Immunotherapy Achieves Critical Patient Milestone - StockTitan

Feb 10, 2025
pulisher
Feb 06, 2025

Greenwich LifeSciences: Long Time To Results, Little Cash, Hard To Recommend (GLSI) - Seeking Alpha

Feb 06, 2025
pulisher
Feb 06, 2025

(GLSI) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 06, 2025
pulisher
Jan 30, 2025

EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial - Yahoo Finance

Jan 30, 2025
pulisher
Jan 29, 2025

Greenwich LifeSciences Gets EU Drug Regulator Approval to Add Sites to GLSI-100 Late-Stage Trial - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

Greenwich LifeSciences stock gains on approval to add additional sites to Flamingo-01 in Europe - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe - GlobeNewswire

Jan 29, 2025
pulisher
Jan 29, 2025

Major Breakthrough: Cancer Prevention Trial Goes Europe-Wide as Top Medical Centers Join Forces - StockTitan

Jan 29, 2025
pulisher
Jan 28, 2025

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland - GlobeNewswire

Jan 28, 2025
pulisher
Jan 27, 2025

Greenwich LifeSciences Expands Phase III Breast Cancer Trial Across Poland - StockTitan

Jan 27, 2025
pulisher
Jan 26, 2025

How to Take Advantage of moves in (GLSI) - Stock Traders Daily

Jan 26, 2025
pulisher
Jan 24, 2025

Greenwich LifeSciences gains after GP2 commercial manufacturing update - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Barclays PLC Has $123,000 Stake in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Bullish Greenwich LifeSciences Insiders Loaded Up On US$3.39m Of Stock - Yahoo Finance

Jan 23, 2025
pulisher
Jan 23, 2025

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 - GlobeNewswire

Jan 23, 2025
pulisher
Jan 23, 2025

Harvard, Johns Hopkins Join Greenwich LifeSciences' Phase III Breast Cancer Vaccine Trial - StockTitan

Jan 23, 2025

Greenwich Lifesciences Inc (GLSI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):